
Medical evidence defeats insurer’s non-disclosure defence
The Appeal Tribunal found that the skin cancer had been completely treated, while evidence showed that the insured did not have lung disease.

The Appeal Tribunal found that the skin cancer had been completely treated, while evidence showed that the insured did not have lung disease.

The Appeal Tribunal found that an undisclosed diagnostic test was not material to the insurer’s assessment of the risk and ordered the claim to be paid.

The Appeal Tribunal found that voluntary pre-claim benefit increases were distinct from post-claim escalation and could not be used to support a fixed 10% increase.

The ruling highlights the need for the timely communication of beneficiary changes in life insurance policies.